Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
26.40
+0.18 (0.69%)
Nov 21, 2024, 4:00 PM EST - Market closed

Royalty Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
15,55412,49717,43217,11619,426-
Upgrade
Market Cap Growth
4.05%-28.31%1.85%-11.89%--
Upgrade
Enterprise Value
21,72721,13227,33326,68728,409-
Upgrade
Last Close Price
26.4027.2437.3637.0045.72-
Upgrade
PE Ratio
10.3410.75382.0324.8334.67-
Upgrade
Forward PE
6.337.4710.3213.0019.16-
Upgrade
PS Ratio
5.225.317.797.489.15-
Upgrade
PB Ratio
1.711.241.831.671.96-
Upgrade
P/TBV Ratio
1.851.923.112.974.06-
Upgrade
P/FCF Ratio
5.564.188.138.489.55-
Upgrade
P/OCF Ratio
5.564.188.138.489.55-
Upgrade
PEG Ratio
1.602.650.941.121.97-
Upgrade
EV/Sales Ratio
9.598.9812.2211.6613.39-
Upgrade
EV/EBITDA Ratio
-14.1129.4418.3616.87-
Upgrade
EV/EBIT Ratio
14.0714.1629.6218.6517.11-
Upgrade
EV/FCF Ratio
7.767.0712.7513.2313.96-
Upgrade
Debt / Equity Ratio
0.740.610.750.690.591.02
Upgrade
Debt / EBITDA Ratio
-4.107.664.883.462.37
Upgrade
Debt / FCF Ratio
2.722.053.323.522.863.76
Upgrade
Asset Turnover
0.130.140.130.140.150.15
Upgrade
Quick Ratio
1.537.872.1116.778.732.50
Upgrade
Current Ratio
1.547.902.1916.818.762.50
Upgrade
Return on Equity (ROE)
17.28%17.34%2.33%12.32%21.23%46.04%
Upgrade
Return on Assets (ROA)
5.69%5.62%3.36%5.33%7.29%13.77%
Upgrade
Return on Capital (ROIC)
5.75%5.68%3.39%5.41%7.38%13.97%
Upgrade
Earnings Yield
7.36%9.08%0.25%3.62%5.02%-
Upgrade
FCF Yield
18.00%23.91%12.30%11.79%10.47%-
Upgrade
Dividend Yield
3.18%2.94%2.03%1.84%0.66%-
Upgrade
Payout Ratio
32.89%31.58%778.21%46.02%40.80%31.48%
Upgrade
Buyback Yield / Dilution
-33.46%-37.66%-5.59%-10.48%--
Upgrade
Total Shareholder Return
-30.28%-34.72%-3.55%-8.64%0.66%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.